Vioxx
Submit form for Free Case Evaluation.
Vioxx Press Room: Coming Soon.
Vioxx, the trade name of the generic drug rofecoxib, was approved by the U.S. Food and Drug Administration (FDA) in May 1999, for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults.
In August 22, 2001, a study published in the Journal of the American Medical Association (JAMA) by Drs. Mukherjee, Nissen, and Topol, researchers from the Cleveland Clinic, indicated that Vioxx was linked to a 200% increase in blood clots, heart attacks and strokes based on their review of previous clinical trials.
In September 2001, the American Heart Association, the National Stroke Association and the Arthritis Foundation asked Merck to test whether Vioxx increased the risk of heart attack and stroke.
On September 30, 2004, Merck & Co., Inc., the manufacturer of Vioxx, announced a voluntary withdrawal of the arthritis and pain relief drug from the worldwide drug market, after results from a clinical trial indicated that Vioxx users may have an increased risk of suffering a heart attack, stroke, or other cardiovascular event.
If you have serious heart problem such as a pulmonary embolism, stroke or a heart attack, or have been diagnosed with Stephens Johnson Syndrome or kidney damage while taking the prescription drug Vioxx, you need to speak to one of our drug litigation attorneys.
We represent Vioxx victims nationwide and your medical problems may indicate you have a have a claim for compensation against the drug's manufacturer, Merck.
If you or a loved one suffered a blood clots, heart attacks and/or stroke while on Vioxx or within a year of Vioxx use, you may be entitled to a substantial recovery. Submit form for Free Case Evaluation.
BextraRashAttorney.com